Publications

  1. Colon-Otero G, Li CY, Dewald GW, White WL. Erythrophagocytic acute lymphocytic leukemia with B-cell markers and with a 20q- chromosome abnormality. Mayo Clin Proc. 1984 Oct; 59(10):678-82.
    View PubMed
  2. Colon-Otero G, Menke D, Hook CC. A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. Med Clin North Am. 1992 May; 76(3):581-97.
    View PubMed
  3. Menke DM, Greipp PR, Colon-Otero G, Solberg LA Jr, Cockerill KJ, Hook CC, Witzig TE. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders. Arch Pathol Lab Med. 1994 Aug; 118(8):811-4.
    View PubMed
  4. Witzig TE, Letendre L, Gerstner J, Schroeder G, Mailliard JA, Colon-Otero G, Marschke RF, Windschitl HE. Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial. J Clin Oncol. 1995 Aug; 13(8):2012-5.
    View PubMed
  5. Colon-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Cancer J Sci Am. 1997 Sep-Oct; 3(5):297-302.
    View PubMed
  6. O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol. 1998 Jul; 16(7):2528-33.
    View PubMed
  7. Colon-Otero G, Moreno A, Tefferi A. A critical review of new treatments for the myelodysplastic syndromes. Cancer Research, Therapy & Control. 1999; 9(3-4):281-88.
  8. Menke DM, Griesser H, Moder KG, Tefferi A, Luthra HS, Cohen MD, Colon-Otero G, Lloyd RV. Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol. 2000 Feb; 113(2):212-8.
    View PubMed
  9. Kuriakose P, Colon-Otero G, Paz-Fumagalli R. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective study. J Vasc Interv Radiol. 2002 Feb; 13(2 Pt 1):179-84.
    View PubMed
  10. Moreno A, Colon-Otero G, Solberg LA Jr. The prednisone dosage in the CHOP chemotherapy regimen for non-Hodgkin's lymphomas (NHL): is there a standard? Oncologist. 2000; 5(3):238-49.
    View PubMed
  11. McLaughlin MP, Sevin BU, Colon-Otero G, Pettit PDM. Radiosensitizing approaches to patients with advanced cervical cancer. Cancer Research, Therapy & Control. 2000; 10(4):279-285.
    View PubMed
  12. Schild SE, Wharen RE Jr, Menke DM, Folger WN, Colon-Otero G. Primary lymphoma of the spinal cord. Mayo Clin Proc. 1995 Mar; 70(3):256-60.
    View PubMed
  13. Colon-Otero G, Malkasian GD, Edmonson JH. Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer. J Natl Cancer Inst. 1993 Nov 17; 85(22):1858-60.
    View PubMed
  14. Perniciaro C, Kuechle MK, Colon-Otero G, Raymond MG, Spear KL, Pittelkow MR. Paraneoplastic pemphigus: a case of prolonged survival. Mayo Clin Proc. 1994 Sep; 69(9):851-5.
    View PubMed
  15. Colon-Otero G, Cockerill KJ, Bowie EJW. The diagnosis of bleeding disorders. Postgrad Med. 1991 Sep; 90:145-150.
    View PubMed
  16. Edmonson JH, Hartmann LC, Long HJ, Colon-Otero G, Fitch TR, Jefferies JA, Braich TA, Maples WJ. Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin. Cancer. 1992 Nov 15; 70(10):2529-39.
    View PubMed
  17. Colon-Otero G, Sando JJ, Sims JL, McGrath E, Quesenberry PJ. Inhibition of hemopoietic growth factor-induced proliferation by ADP-ribosylation inhibitors. Blood. 1987 Sep; 70:686-693.
    View PubMed
  18. Kyle RA, Colon-Otero G, Shampo MA. Jaime Ferran y Clua: bacteriologist. Mayo Clin Proc. 1988 Apr; 63(4):418.
    View PubMed
  19. Colon-Otero G, McClure SP, Phyliky RL, White WL, Banks PM. Peripheral T-cell lymphoma simulating Hodgkin's disease with initial bone marrow involvement. Mayo Clin Proc. 1986 Jan; 61(1):68-71.
    View PubMed
  20. Colon-Otero G, Gilchrist GS, Holcomb GR, Ilstrup DM, Bowie EJ. Preoperative evaluation of hemostasis in patients with congenital heart disease. Mayo Clin Proc. 1987 May; 62(5):379-85.
    View PubMed
  21. Kempson SA, Colon-Otero G, Ou SY, Turner ST, Dousa TP. Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin Invest. 1981 May; 67(5):1347-60.
    View PubMed
  22. Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. Blood. 2002 May 15; 99(10):3854-6.
    View PubMed
  23. Kumar S, Menke DM, Dewald GW, Colon-Otero G. Agnogenic myeloid metaplasia associated with Klinefelter syndrome: a case report. Ann Hematol. 2002 Apr; 81(4):215-8. Epub 2002 Mar 07.
    View PubMed
  24. Menke DM, Colon-Otero G, Cockerill KJ, Jenkins RB, Noel P, Pierre RV. Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol. 1992 Nov; 98(5):502-10.
    View PubMed
  25. Andrews TR, Colon-Otero G, Calamia KT, Menke DM, Boylan KB, Kyle RA. Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy. Mayo Clin Proc. 2002 Dec; 77(12):1287-90.
    View PubMed
  26. Solberg LA Jr, et al. Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group. Am J Med 1992 Jan; 92 (1):69-76
    View PubMed
  27. Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A, Litzow MR, Roy V, Hogan WJ, Kyle RA, Gertz MA. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004 Nov 15; 104(10):3400-7. Epub 2004 Jul 27.
    View PubMed
  28. Colon-Otero G, Davis TH, Elkins S, Kosty MP, Mudad R, Niell HB, Wozniak AJ. Oncology Board Review study guide. American Journal of Oncology Review. 2004 Nov; 3(11 Suppl 10):1-20.
    View PubMed
  29. Colon-Otero G, Smallridge RC, Solberg LA Jr, Keith TD, Woodward TA, Willis FB, Dunn AN. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis. Cancer. 2008 Feb 1; 112(3):447-54.
    View PubMed
  30. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion. 2008 Jun; 48(6):1106-14. Epub 2008 Feb 25.
    View PubMed
  31. Palmieri FM, DePeri ER, Mincey BA, Smith JA, Wen LK, Chewar DM, Abaya R, Colon-Otero G, Perez EA. Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population. Mayo Clin Proc. 2009 Apr; 84(4):317-22.
    View PubMed
  32. Moreno-Aspitia A, Colon-Otero G, Hoering A, Tefferi A, Niedringhaus RD, Vukov A, Li CY, Menke DM, Geyer SM, Alberts SR, North Central Cancer Treatment Group. Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trial. Cancer. 2006 Aug 15; 107(4):767-72.
    View PubMed
  33. Young PM, Paz-Fumagalli R, Colon-Otero G, Sevin BU. Postoperative pseudoaneurysm after debulking surgery for ovarian cancer: Long-term success of percutaneous thrombin injection. J Gynecol Surg. 2006; 22(2):77-80.
    View PubMed
  34. Colon-Otero G, Niedringhaus RD, Hillman SH, Geyer S, Sloan J, Krook JE, Windschitl HE, Marks RS, Wiesenfeld M, Tschetter LK, Jett JJ, North Central Cancer Treatment Group. A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial. Am J Clin Oncol. 2001 Dec; 24(6):551-5.
    View PubMed
  35. Armstrong MD, Von Hoff, Barber B, Marlow LA, von Roemeling, Cooper SJ, Travis P, Campbell E, Paz-Fumagalli R, Copland JA, Colon-Otero G. An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development. J Cancer. 2011; 2:142-52 Epub 2011 Mar 8.
    View PubMed
  36. Kyle RA, Colon-Otero G, Shampo MA. Jaime Ferran y Clua: bacteriologist. Mayo Clin Proc. 1998 Apr; 63(4):418.
  37. Colon-Otero G, King S, Smith V, Bieber C, Crook J, Solberg LA, Shannon R, Perez EA. Increased incidence of loco-regional recurrences among african american women with terminal stage breast cancer. Clin Med Oncol. 2008; 2:547-50. Epub 2008 Nov 03.
    View PubMed
  38. Colon-Otero G, Albertie M, Lesperance M, Weis JA, Coles A, Smith N, Mills L, Woodward T, Aspitia AM, Vishnu P, Willis F, Isley A, Fonseca R, Vachon C, Rajkumar SV. A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans. J Cancer Educ. 2012 Jun; 27(2):294-8.
    View PubMed
  39. Shannon RP, Gwin DK, Colon-Otero G, Howick PH. The palliative care consultation service: optimizing quality of life when quantity of life is limited. Northeast Florida Medicine. 2006; 57(4):35-9.
  40. Vishnu P, Colon-Otero G, Kennedy GT, Marlow LA, Kennedy WP, Wu KJ, Santoso JT, Copland JA. RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer. Gynecol Oncol. 2012 Mar; 124(3):589-97. Epub 2011 Nov 22.
    View PubMed
  41. Hendrickson AE, Oberg AL, Glaser G, Camoriano JK, Peethambaram PP, Colon-Otero G, Erlichman C, Ivy SP, Kaufmann SH, Karnitz LM, Haluska P. A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2012 Feb; 124(2):210-5. Epub 2011 Nov 01.
    View PubMed
  42. Patel TA, Colon-Otero G, Bueno Hume, Copland JA, Perez EA. Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups. Oncologist. 2010; 15(5):466-75. Epub 2010 Apr 28.
    View PubMed
  43. Dyar S, Lesperance M, Shannon R, Sloan J, Colon-Otero G. A nurse practitioner directed intervention improves the quality of life of patients with metastatic cancer: results of a randomized pilot study. J Palliat Med. 2012 Aug; 15(8):890-5. Epub 2012 May 04.
    View PubMed
  44. Moreno-Aspitia A, Dueck AC, Ghanem-Canete I, Patel T, Dakhil S, Johnson D, Franco S, Kahanic S, Colon-Otero G, Tenner KS, Rodeheffer R, McCullough AE, Jenkins RB, Palmieri FM, Northfelt D, Perez EA. RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer. Breast Cancer Res Treat. 2013 Apr; 138(2):427-35. Epub 2013 Mar 12.
    View PubMed
  45. Lesperance M, Shannon R, Pumphrey PK, Dunbar E, Genther R, Coleman CL, Tabano M, Maurer J, Vazquez A, Capp E, McMillan J, Wilkerson K, Robbins G, Phillips DG, Howick P, Solaun C, Sloan J, Colon-Otero G. Training mid-level providers on palliative care: bringing advanced directives and symptom assessment and management to community oncology practices. Am J Hosp Palliat Care. 2014 May; 31(3):237-43. Epub 2013 Apr 23.
    View PubMed
  46. Colón-Otero G, Albertie M, Rodríguez J, Correa-Matos N, Nicholson G, Kolomeyer I, Moreno-Aspitia A, Lesperance L, Watson C, Perez EA. A Church-Based, Spanish-Language Community Education Breast Health Program Increases Awareness and Utilization of Breast Diagnostic Services among Hispanics. Journal of Higher Education Outreach and Engagement. 2013.
  47. Cooper SJ, von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, Tun HW, Colon-Otero G, Perez EA, Copland JA. Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Cancer Ther. 2012 Oct; 11(10):2105-15. Epub 2012 Jul 23.
    View PubMed
  48. Paulus A, Masood A, Miller KC, Khan AN, Akhtar D, Advani P, Foran J, Rivera C, Roy V, Colon-Otero G, Chitta K, Chanan-Khan A. The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs. Br J Haematol 2014 Apr; 165 (1):78-88 Epub 2014 Jan 27
    View PubMed
  49. Colon-Otero G. Out of the woods, a Mayo Clinic emerges: a commentary on the history of Mayo Clinic in Florida. Mayo Clin Proc. 2014 May; 89(5):583-8.
    View PubMed
  50. Patel TA, Dave B, Rodriguez AA, Chang JC, Perez EA, Colon-Otero G. Dual HER2 blockade: preclinical and clinical data. Breast Cancer Res. 2014; 16(4):419. Epub 2014 Aug 01.
    View PubMed
  51. Perez EA, Romond EH, Suman VJ, Jeong JH, Sledge G, Geyer CE Jr, Martino S, Rastogi P, Gralow J, Swain SM, Winer EP, Colon-Otero G, Davidson NE, Mamounas E, Zujewski JA, Wolmark N. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. J Clin Oncol. 2014 Nov 20; 32(33):3744-52. Epub 2014 Oct 20.
    View PubMed
  52. Noriega-Iriondo MF, Colon-Otero G, Kipp BR, Copland JA, Ferber MJ, Marlow LA, Roberts ME, Robertson MW, Dinh TA, Attia S, Geiger XJ, Riegert-Johnson DL. High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case report. Hered Cancer Clin Pract. 2015; 13(1):6. Epub 2015 Jan 23
    View PubMed
  53. Mauras N, Santen RJ, Colon-Otero G, Hossain J, Wang Q, Mesaros C, Blair IA. Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls. J Clin Endocrinol Metab. 2015 Jun; 100(6):2322-8. Epub 2015 Apr 09.
    View PubMed
  54. Crozier JA, Sher T, Yang D, Swaika A, Foran J, Ghosh R, Tun H, Colon-Otero G, Kelly K, Chanan-Khan A, Ailawadhi S. Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review. Clin Lymphoma Myeloma Leuk. 2015 Oct; 15(10):578-85. Epub 2015 Jun 19.
    View PubMed
  55. Advani PP , Ballman KV , Dockter TJ , Colon-Otero G , Perez EA . Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial. J Clin Oncol 2016 Feb 20; 34 (6):581-7 Epub 2015 Sept 21
    View PubMed
  56. Ailawadhi S, Advani P, Yang D, Ghosh R, Swaika A, Roy V, Foran J, Colon-Otero G, Chanan-Khan A. Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis. Cancer 2016 Feb 15; 122 (4):618-25 Epub 2015 Nov 13
    View PubMed
  57. Colon-Otero G, Albertie M, Rodríguez J, Nicholson G, Kolomeyer I, Moreno-Aspitia A, Lesperance M, Perez EA. A Church-Based, Spanish-Language Community Education Breast Health Program Increases Awareness, Utilization of Breast Diagnostic Services Among Hispanics. Journal of Higher Education Outreach and Engagement.2014;18:(1):43-59.
  58. Weekes CD , Lamberts LE , Borad MJ , Voortman J , McWilliams RR , Diamond JR , de Vries EG , Verheul HM , Lieu CH , Kim GP , Wang Y , Scales SJ , Samineni D , Brunstein F , Choi Y , Maslyar DJ , Colon-Otero G . Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer. Mol Cancer Ther 2016 Mar; 15 (3):439-47 Epub 2016 Jan 28
    View PubMed
  59. Hall JC , Marlow LA , Mathias AC , Dawson LK , Durham WF , Meshaw KA , Mullin RJ , Synnott AJ , Small DL , Krishna M , von Hoff D , Schuler J , Hart SN , Couch FJ , Colon-Otero G , Copland JA . Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin. J Transl Med 2016; 14 (1):129 Epub 2016 May 10
    View PubMed